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Changes have been made according to difficulties 
encountered so far., e.g. Recruitment sites and 
patients age. 
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Portuguese population is  double-aging, with a 
current aging index of 129.4%, the 5th highest in 
Europe1. Old age is often associated with a high 
comorbidity index, polymedication and various 
DRPs, including adherence problems and 
potentially inappropriate medications (PIMs). 
Pharmacists have a role in medicines review of 
these patients and several tools have been 
developed to assist  them in such task2,4 .  
• To develop a university-based programme where 
students actively engage in managing the 
medication of elderly patients. 
• To test the feasibility of such approach.
•To evaluate the impact of medication review on 
patient outcomes (clinical and humanistic).
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Patient follow-up=3 months
Outcome measures: adherence (pill-count and 
MMAS-4); PIMs detected and removed; POMs 
detected and added; proxy measures when 
appropriate (e.g. Glycemia, B.P.)
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While the interventions designed were planned to 
be theoretically more useful for patients living
alone, the difficulty found in recruitment sites 
is shifting the focus from home medicines
review to residential medicines review.
Students are motivated with this project and have
offered to become active parts in site 
recruitment.
Working Symposium of the Pharmaceutical Care Network Europe (PCNE). Malta, 14-15 
March 2014
4 Residential
facilities
0 Day Care
Centres
12 Community
Pharmacies
Short of staff 
(n=3)
Waiting for 
decision (n=13)
Table 1: Baseline characteristics of residential patients (3 facilities)
 Intervention Control p 
 n (%) n (%)  
Gender (female) 31 (48.4%) 33 (51.6%) 0.547 
 M (SD) M (SD)  
Age 84.91 (6.738) 83.72 (6.825) 0.413 
Comoribidities 4.09 (1.998) 4.45 (2.050) 0.409 
Number of medicines 9.89 (4.877) 9.67 (3.797) 0.816 
Daily dosages 11.39 (7.268) 11.70 (4.998) 0.819 
 
